UPDATE: Morgan Stanley Reiterates Overweight Rating, Raises PT on Constellium NV as More Catalysts are Expected

Loading...
Loading...
In a report published Wednesday, Morgan Stanley analyst Paretosh Misra reiterated an Overweight rating on
Constellium NVCSTM
, and raised the price target from $25.00 to $34.00. In the report, Morgan Stanley noted, “We expect CSTM to re-rate further on a strong end market outlook. Raising PT to $34; the expected catalyst: more automakers using aluminum sheet. We expect CSTM to capture ~22% of a >2.0 mmt global market and earn €2.75 in 2017e (vs. €1.25 in 2013e). Every 0.4kT of demand drives ~€0.25 in EPS.” Constellium NV closed on Tuesday at $28.13.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsMorgan StanleyParetosh Misra
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...